시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 척수 자극 기기 시장 보고서(2025년)
Spinal Cord Stimulation Devices Global Market Report 2025
상품코드 : 1717316
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,219,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,990,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,761,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

척수 자극기 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 연평균 성장률(CAGR) 8.75%로 41억 8,000만 달러로 성장합니다. 예측 기간 중 만성 통증 질환의 유병률 증가, 비오피오이드 기반 통증 관리 솔루션에 대한 수요 증가, 노인 인구 증가, 지원적인 상환 정책, 무선 및 충전식 장비 채택 증가, 의료 전문가 및 환자의 신경조절 요법에 대한 인식 증가 등이 성장의 원동력이 될 것으로 보입니다. 성장의 원동력이 될 것으로 보입니다. 향후 예상되는 주요 동향으로는 최소침습 기술의 발전, 무선 및 충전식 기기의 혁신, 주파수 자극의 개선, 폐쇄 루프 피드백 시스템의 채택, 무선 연결의 통합, 고급 파형 옵션의 개발, 개인화된 통증 관리 알고리즘의 사용 등이 있습니다.

만성 통증의 유병률 증가는 척수 자극(SCS) 장비 시장의 성장을 가속할 것으로 예측됩니다. 만성통증은 12주 이상 지속되는 지속적인 통증을 특징으로 하며, 관절염, 신경장애, 요통 등의 증상으로 인해 발생하는 경우가 많습니다. 이러한 증가는 고령화, 생활습관 변화, 만성 건강 상태, 부상 및 외상 등의 요인으로 인해 발생하며, SCS 장비는 전기 자극을 공급하여 통증 신호를 수정함으로써 만성 통증을 완화하고 장기적인 증상 완화를 가져옴으로써 만성 통증을 완화합니다. 예를 들어 2024년 11월 미국 질병예방통제센터(CDC)는 2023년 성인의 24.3%가 만성통증을 경험하고, 8.5%가 심각한 만성통증을 경험하며, 만성통증 사례의 34.9%를 차지할 것이라고 보고했습니다. 이러한 추세는 만성통증을 효과적으로 관리하기 위한 SCS 장비에 대한 수요 증가를 지원합니다.

척수 자극기(SCS) 시장의 주요 업체들은 환자 치료를 강화하고, 장비의 수명을 연장하며, 만성 통증 환자에게 맞춤형 통증 관리 솔루션을 제공하기 위해 충전식 SCS 시스템과 같은 첨단 기술 개발을 우선순위에 두고 있습니다. 이러한 충전식 SCS 시스템은 전기 자극을 사용하여 척수를 타겟으로 만성 통증을 완화하는 첨단 의료기기입니다. 예를 들어 미국의 유명한 의료기기 제조업체인 Abbott Laboratories는 2022년 12월에 척수 자극 시스템 Eterna에 대한 FDA 승인을 획득했습니다. 이 혁신적인 솔루션은 컴팩트하고 환자 친화적인 디자인과 편안함을 높이고 사용자의 신체적 부담을 줄여주는 첨단 기능을 결합하여 만성 통증 관리에 혁명을 일으킬 수 있도록 설계되었습니다. 충전식이기 때문에 기기의 수명이 길어 잦은 수술적 교체 필요성을 최소화하고 편의성을 향상시킵니다. 또한 이 시스템은 정확한 자극을 제공하므로 각 환자의 고유한 요구에 맞는 맞춤형 통증 완화가 가능합니다. 합리적인 디자인은 최소 침습적 이식을 지원하고 빠른 회복 시간을 촉진하며 전반적인 환자 결과를 개선합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Spinal cord stimulation (SCS) devices are implantable medical devices that help manage chronic pain by delivering gentle electrical pulses to the spinal cord. These pulses disrupt pain signals before they reach the brain, providing relief. SCS devices combine advanced neurotechnology with customizable programming, offering a minimally invasive treatment for conditions such as neuropathic pain and failed back surgery syndrome.

The primary types of SCS devices include implantable and non-implantable stimulators. Implantable spinal cord stimulators are surgically placed under the skin and deliver electrical pulses directly to the spinal cord, interfering with pain signals to alleviate chronic discomfort. SCS devices are further categorized into rechargeable and non-rechargeable types. They are used for various applications, including failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease, unsuccessful disk surgery, and other chronic pain conditions. End users include hospitals, ambulatory surgical centers, and neuro clinics.

The spinal cord stimulation devices market research report is one of a series of new reports from The Business Research Company that provides spinal cord stimulation devices market statistics, including the spinal cord stimulation devices industry's global market size, regional shares, competitors with a spinal cord stimulation devices market share, detailed spinal cord stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the spinal cord stimulation devices industry. This spinal cord stimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The spinal cord stimulation devices market size has grown strongly in recent years. It will grow from $2.74 billion in 2024 to $2.99 billion in 2025 at a compound annual growth rate (CAGR) of 9.01%. The growth during the historic period was driven by improved clinical outcomes and higher patient satisfaction, increased awareness of pain management alternatives, expanded reimbursement support, a rise in clinical research and regulatory approvals, and the growth of pain management clinics and centers.

The spinal cord stimulation devices market size is expected to see strong growth in the next few years. It will grow to $4.18 billion in 2029 at a compound annual growth rate (CAGR) of 8.75%. In the forecast period, growth is expected to be fueled by the increasing prevalence of chronic pain conditions, rising demand for non-opioid pain management solutions, a growing geriatric population, supportive reimbursement policies, heightened adoption of wireless and rechargeable devices, and greater awareness of neuromodulation therapies among healthcare professionals and patients. Key trends anticipated include advancements in minimally invasive technologies, innovations in wireless and rechargeable devices, improvements in frequency stimulation, adoption of closed-loop feedback systems, integration of wireless connectivity, the development of advanced waveform options, and the use of personalized pain management algorithms.

The increasing prevalence of chronic pain is expected to propel the growth of the spinal cord stimulation (SCS) devices market. Chronic pain, characterized by persistent pain lasting 12 weeks or longer, often arises from conditions such as arthritis, neuropathy, or low back pain. This increase is driven by factors such as an aging population, lifestyle changes, chronic health conditions, and injuries or trauma. SCS devices help alleviate chronic pain by delivering electrical impulses to modify pain signals, offering relief for long-term conditions. For example, in November 2024, the Centers for Disease Control and Prevention (CDC) reported that in 2023, 24.3% of adults experienced chronic pain, with 8.5% reporting high-impact chronic pain, accounting for 34.9% of chronic pain cases. These trends underscore the rising demand for SCS devices in managing chronic pain effectively.

Leading companies in the spinal cord stimulation (SCS) devices market are prioritizing the development of advanced technologies, such as rechargeable SCS systems, to enhance patient care, extend device lifespan, and offer tailored pain management solutions for chronic pain sufferers. These rechargeable SCS systems are sophisticated medical devices that use electrical impulses to alleviate chronic pain by targeting the spinal cord. For example, in December 2022, Abbott Laboratories, a prominent US-based medical device manufacturer, secured FDA approval for its Eterna spinal cord stimulation system. This innovative solution is designed to revolutionize chronic pain management by combining a compact, patient-friendly design with advanced features that enhance comfort and reduce the physical burden on users. The rechargeable capability ensures the device's longevity, minimizing the need for frequent surgical replacements and boosting convenience. Moreover, the system offers precise stimulation, enabling customized pain relief tailored to each patient's unique needs. Its streamlined design supports minimally invasive implantation, promoting faster recovery times and improving overall patient outcomes.

In November 2023, Boston Scientific Corporation strengthened its chronic pain treatment portfolio by acquiring Relevant Medsystems Inc. for $850 million. This acquisition added basivertebral nerve ablation therapy, provided by Relevant Medsystems, to Boston Scientific's suite of chronic pain solutions, which includes spinal cord stimulation devices. Relevant Medsystems, known for its innovative chronic pain management technologies, enhances Boston Scientific's ability to offer comprehensive treatment options for patients suffering from persistent pain.

Major players in the spinal cord stimulation devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nevro Corp., Bluewind Medical, NeuroPace Inc., Vertos Medical Inc., SPR Therapeutics Inc., Saluda Medical Pty Ltd., Stimwave Technologies Inc., Nuvectra Inc., Soterix Medical Inc., Synapse Biomedical, ONWARD Medical NV, NeuroSigma Inc., Nalu Medical Inc., Neurostim Technologies, SpineX Inc., Aleva Neurotherapeutics SA, GTX Medical BV.

North America was the largest region in the spinal cord stimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in spinal cord stimulation devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the spinal cord stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spinal cord stimulation devices market consists of sales of implantable pulse generators (IPGs), leads and electrodes, MRI-compatible SCS devices, and hybrid stimulation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spinal Cord Stimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spinal cord stimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for spinal cord stimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spinal cord stimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Spinal Cord Stimulation Devices Market Characteristics

3. Spinal Cord Stimulation Devices Market Trends And Strategies

4. Spinal Cord Stimulation Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Spinal Cord Stimulation Devices Growth Analysis And Strategic Analysis Framework

6. Spinal Cord Stimulation Devices Market Segmentation

7. Spinal Cord Stimulation Devices Market Regional And Country Analysis

8. Asia-Pacific Spinal Cord Stimulation Devices Market

9. China Spinal Cord Stimulation Devices Market

10. India Spinal Cord Stimulation Devices Market

11. Japan Spinal Cord Stimulation Devices Market

12. Australia Spinal Cord Stimulation Devices Market

13. Indonesia Spinal Cord Stimulation Devices Market

14. South Korea Spinal Cord Stimulation Devices Market

15. Western Europe Spinal Cord Stimulation Devices Market

16. UK Spinal Cord Stimulation Devices Market

17. Germany Spinal Cord Stimulation Devices Market

18. France Spinal Cord Stimulation Devices Market

19. Italy Spinal Cord Stimulation Devices Market

20. Spain Spinal Cord Stimulation Devices Market

21. Eastern Europe Spinal Cord Stimulation Devices Market

22. Russia Spinal Cord Stimulation Devices Market

23. North America Spinal Cord Stimulation Devices Market

24. USA Spinal Cord Stimulation Devices Market

25. Canada Spinal Cord Stimulation Devices Market

26. South America Spinal Cord Stimulation Devices Market

27. Brazil Spinal Cord Stimulation Devices Market

28. Middle East Spinal Cord Stimulation Devices Market

29. Africa Spinal Cord Stimulation Devices Market

30. Spinal Cord Stimulation Devices Market Competitive Landscape And Company Profiles

31. Spinal Cord Stimulation Devices Market Other Major And Innovative Companies

32. Global Spinal Cord Stimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Spinal Cord Stimulation Devices Market

34. Recent Developments In The Spinal Cord Stimulation Devices Market

35. Spinal Cord Stimulation Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기